Physical Training in Metabolic Syndrome: Clinical and Physiological Evidence

Abstract

Metabolic syndrome (MS) is characterized by the coexistence of metabolic disturbances such as insulin resistance, central obesity, dyslipidemia, and hypertension, which significantly increase the risk of cardiovascular diseases and type 2 diabetes. Physical training plays a central role in the prevention and treatment of MS by promoting physiological adaptations and widely documented clinical benefits. Evidence shows that aerobic exercise improves insulin sensitivity, endothelial function, and lipid profile, while resistance training contributes to increased lean mass, higher basal energy expenditure, and reduced visceral adiposity. Combined protocols (aerobic + resistance) produce superior synergistic effects on body composition and systemic inflammatory markers. Physiological mechanisms include increased mitochondrial biogenesis, reduced oxidative stress, regulation of adipokines, and improved peripheral glucose uptake mediated by GLUT-4. Clinically, structured exercise programs performed at least three times per week, at moderate to vigorous intensity, are effective in reversing syndrome components and reducing overall cardiovascular risk. Thus, physical training represents a highly relevant non-pharmacological intervention in the integrated management of metabolic syndrome, with a positive impact on metabolic physiology and patients’ quality of life.

Share and Cite:

Pasco, R. (2025) Physical Training in Metabolic Syndrome: Clinical and Physiological Evidence. Open Journal of Regenerative Medicine, 14, 27-36. doi: 10.4236/ojrm.2025.143003.

1. Introduction

The prevalence of metabolic syndrome (MS) has been rapidly increasing in both developed and developing countries and is commonly associated with obesity [1].

MS is a multifactorial clinical condition characterized by a cluster of metabolic disturbances that include central obesity, insulin resistance, dyslipidemia, and arterial hypertension. This grouping of risk factors is associated with a significant increase in cardiovascular morbidity and mortality, as well as a higher risk of developing type 2 diabetes mellitus [2]. The global rise in MS parallels the growth of sedentary behavior and obesity, reflecting behavioral and environmental changes related to modern lifestyle [3].

It is estimated that approximately one-quarter of the world’s adult population meets the diagnostic criteria for MS, representing a major public health challenge [4]. Lifestyle-based interventions, particularly regular physical training, have been shown to be key strategies in preventing and treating this syndrome [5].

Considering the characteristics of this condition, one of the main treatments to reduce body weight and fat mass involves combining physical exercise with dietary re-education, as this strategy facilitates the establishment of a negative energy balance [6].

Physical exercise promotes several beneficial physiological and metabolic adaptations, among which the improvement of insulin sensitivity, increased energy expenditure and fatty acid oxidation, reduction of visceral adiposity, and positive modulation of inflammatory markers stand out [7]. Additionally, exercise training acts on molecular pathways such as AMPK, PI3K/Akt, and PGC-1α, stimulating mitochondrial biogenesis and reducing oxidative stress—central mechanisms in restoring metabolic homeostasis [8] [9].

From a clinical perspective, evidence shows that structured exercise programs—whether aerobic, resistance, or combined—can significantly reduce abdominal circumference, blood pressure, fasting glucose, and triglyceride levels in individuals with MS [10] [11]. These effects reinforce the role of physical training as a first-line intervention—safe, low-cost, and with a substantial impact on quality of life and cardiovascular prognosis [12].

Although the role of exercise in improving the components of metabolic syndrome is widely recognized, there are still gaps in the integrated understanding of the physiological and molecular mechanisms involved, as well as uncertainties regarding the most effective dose, intensity, and type of training for different patient profiles. Analyzing available clinical evidence, combined with elucidating the underlying mechanisms, is essential to guide personalized strategies for prevention and treatment.

2. Objective

To review the main clinical evidence and the physiological and molecular mechanisms associated with the effects of physical training on metabolic syndrome, highlighting the impacts on energy metabolism, insulin sensitivity, inflammatory profile, and cardiometabolic risk factors.

3. Methodology

This is a narrative literature review aimed at synthesizing the main scientific evidence available on the effects of physical training on the clinical, physiological, and molecular aspects of MS. The literature search was conducted in the PubMed/MEDLINE, Scopus, ScienceDirect, and SciELO databases, including publications from 2010 to 2025.

The following English descriptors were used: metabolic syndrome, exercise training, physical activity, aerobic exercise, resistance training, insulin sensitivity, inflammation, and mitochondrial function. In Portuguese: síndrome metabólica, treinamento físico, atividade física, exercício aeróbico, exercício resistido, and inflamação sistêmica.

Inclusion criteria comprised original articles, systematic reviews, meta-analyses, and controlled clinical trials that investigated the effects of physical exercise on clinical parameters (blood pressure, body composition, glycemia, lipid profile) and physiological parameters (mitochondrial biogenesis, insulin sensitivity, inflammatory markers) in individuals with MS. Exclusion criteria were: studies exclusively with animal models, narrative reviews without a critical approach, articles without full-text access, and publications in languages other than Portuguese or English.

Study selection was conducted in three stages: title screening, abstract analysis, and full-text reading of eligible articles. Extracted information included: author and year, sample characteristics, type and duration of training, main clinical outcomes, and physiological mechanisms. Data were organized descriptively and interpretatively, allowing for an integrated discussion between clinical evidence and underlying physiological mechanisms.

4. Literature Review

4.1. Clinical Effects

Evidence indicates that an adequate lifestyle helps in the management and prevention of metabolic syndrome (MS) and its associated factors. Modification of eating habits and structured exercise prescription should be considered first-line, non-pharmacological and non-invasive treatments to improve MS, providing cardioprotective benefits associated with increased cardiorespiratory fitness [13]. These benefits result largely from improvements in endothelial function and peripheral blood flow, favored by greater nitric oxide (NO) bioavailability and reduced vascular oxidative stress [14].

Resistance (strength) training complements these effects by promoting increases in skeletal muscle mass, higher basal metabolic rate, and enhanced insulin-dependent and insulin-independent glucose uptake, partly mediated by activation of the AMPK pathway [15]. Activation of this pathway clinically contributes to reducing triglycerides, improving lipid profile, and enhancing glycemic control through increased fatty acid oxidation and intramuscular glucose uptake, in addition to inhibiting hepatic lipogenesis—fundamental processes in controlling MS components [16] [17]. This modality also aids in preserving lean mass and attenuating metabolic sarcopenia, which is frequently observed in individuals with MS and central obesity [18].

The literature shows that combining aerobic and resistance training potentiates visceral fat reduction, optimizes lipid profile, and increases cardiorespiratory fitness (VO2max), considered one of the strongest predictors of cardiovascular mortality [19] [20]. Thus, integrating different training modalities represents an effective and clinically relevant strategy for comprehensive management of metabolic syndrome.

4.2. Molecular and Metabolic Adaptations

From a molecular and bioenergetic perspective, exercise activates the AMPK–PGC-1α pathway, which is essential for mitochondrial biogenesis and increased oxidative capacity of skeletal muscle [21] [22].

AMPK activation plays a central role in improving the lipid profile by stimulating metabolic pathways that increase fatty acid oxidation and reduce hepatic lipid synthesis. Once activated, AMPK inhibits acetyl-CoA carboxylase (ACC), decreasing malonyl-CoA production and consequently releasing carnitine palmitoyltransferase-1 (CPT-1) to enhance fatty acid transport into mitochondria for oxidation. Simultaneously, AMPK reduces the activity of HMG-CoA reductase and the transcription factor SREBP-1c, leading to decreased hepatic lipogenesis and cholesterol synthesis. These combined effects result in lower plasma triglyceride and LDL-cholesterol levels, favoring a more efficient and cardioprotective metabolic environment [23] [24].

4.3. Immunometabolic Modulation

Physical exercise also directly impacts the immunometabolic system by promoting a shift in adipose tissue macrophages from a pro-inflammatory (M1) to an anti-inflammatory (M2) phenotype [25]. This shift is accompanied by increased secretion of myokines with beneficial metabolic effects, such as irisin, IL-6, IL-10, and SPARC, which promote thermogenesis, lipolysis, and improved energy metabolism [26] [27].

The myokine IL-6, when acutely released during exercise, exerts systemic anti-inflammatory effects by inhibiting TNF-α production and stimulating IL-10 secretion [28].

4.4. Endocrine Axis

The effect of physical exercise on insulin sensitivity may last 12 to 48 hours after a training session but returns to baseline within three to five days after the last session, reinforcing the need for regular and frequent physical activity [29].

4.5. Epigenetic Effect

In addition to metabolic and inflammatory adaptations, recent evidence indicates that exercise influences epigenetic mechanisms such as DNA methylation and histone modification, modulating the expression of genes involved in energy metabolism and inflammation [30]. These epigenetic changes appear to mediate part of the sustained benefits of exercise, even after temporary interruptions in training.

A well-documented example is the epigenetic modulation of the PGC-1α gene, considered a central regulator of mitochondrial biogenesis and oxidative metabolism. Studies show that acute exercise sessions reduce methylation in promoter regions of PGC-1α, increasing its expression and promoting metabolic adaptations such as greater oxidative capacity and improved insulin sensitivity [31] [32]. These findings reinforce that epigenetic alterations may contribute to maintaining metabolic benefits of exercise even after training interruptions.

4.6. Individualization of Exercise Prescription

Another relevant aspect concerns the individualization of exercise prescription. Metabolic response varies according to sex, age, body composition, and presence of comorbidities. Women with MS, for example, tend to show greater resistance to lipid oxidation and more pronounced inflammatory responses, often requiring combined and progressive protocols [33].

Individualization is essential to optimize therapeutic outcomes and ensure safety, especially in patients with MS or other cardiometabolic comorbidities. Factors such as baseline fitness level, functional limitations, and specific clinical conditions guide the choice between aerobic, resistance, or combined programs. Individuals with low cardiorespiratory fitness or advanced obesity may initially benefit from moderate-intensity aerobic exercise with gradual progression as tolerated [34]. Patients with sarcopenia, frailty, or age-related muscle loss tend to respond better when resistance training is prioritized, given its effectiveness in improving strength, increasing lean mass, and reducing inflammatory markers [35] [36].

In situations where multiple risk factors coexist—such as insulin resistance, hypertension, and increased waist circumference—combined programs demonstrate superior benefits by simultaneously promoting cardiorespiratory, metabolic, and musculoskeletal adaptations [37] [38]. Thus, modality selection should always be guided by clinical and functional assessment and individual goals, ensuring a personalized approach that maximizes benefits and minimizes risks.

5. Conclusions

Physical training is a fundamental therapeutic tool for the prevention and treatment of metabolic syndrome (MS), with well-established clinical and molecular benefits. Exercise-induced adaptations—especially through combined aerobic and resistance training—improve insulin sensitivity, reduce systemic inflammation, stimulate mitochondrial biogenesis, and promote metabolic homeostasis. At the molecular level, exercise regulates central metabolic pathways, including AMPK activation, PGC-1α expression, and GLUT4 signaling, contributing to energy balance and preventing metabolic dysfunctions associated with obesity and insulin resistance. Furthermore, regular physical activity exerts cardioprotective effects by modulating plasma lipids, blood pressure, and inflammatory markers—key components in reducing the elevated cardiovascular risk characteristic of individuals with MS.

Beyond these physiological effects, exercise prescription should follow structured, evidence-based guidelines. Current recommendations indicate that adults with MS should perform aerobic exercise 3 to 5 times per week at moderate to vigorous intensity, accumulating 150 - 300 minutes per week of moderate activity or 75 - 150 minutes of vigorous activity [39]. Resistance training is recommended 2 - 3 times per week, involving major muscle groups, with 1 - 3 sets of 8 - 12 repetitions. Combined training (aerobic + resistance) provides the greatest impact on visceral fat reduction, improved insulin sensitivity, and modulation of inflammatory markers [40]. High-intensity interval training (HIIT) may be incorporated for clinically stable individuals, offering superior improvements in cardiorespiratory fitness and glycemic control [41]. Exercise prescription should also be individualized, considering baseline fitness level, comorbidities, and patient preferences to optimize adherence and clinical outcomes [42].

Therefore, physical exercise should be considered a first-line, low-cost, and highly effective intervention with substantial public health impact. Strategies that promote regular participation—particularly when individualized and combined with nutritional guidance—can significantly reduce the incidence, progression, and complications associated with metabolic syndrome.

6. Limitations

Despite their usefulness in synthesizing broad and heterogeneous evidence, narrative reviews present important limitations, particularly regarding the potential for selection bias. Because they do not follow strictly structured protocols—such as explicit inclusion and exclusion criteria, systematic assessment of methodological quality, or standardized search strategies—there is greater subjectivity in the choice of included studies [43] [44]. This flexibility may result in disproportionate emphasis on certain findings, inadvertent exclusion of relevant studies, or overlapping interpretations influenced by the authors’ prior experience [45]. Additionally, the absence of quantitative methods to evaluate the consistency of results limits the strength of the conclusions and reduces reproducibility [46]. Thus, although useful for integrating knowledge and discussing physiological mechanisms, narrative reviews should have their conclusions interpreted with caution, acknowledging the inherent biases of this study design.

Conflicts of Interest

The author declares no conflicts of interest regarding the publication of this paper.

References

[1] Adair, L.S. (2008) Child and Adolescent Obesity: Epidemiology and Developmental Perspectives. Physiology & Behavior, 94, 8-16.[CrossRef] [PubMed]
[2] Alberti, K.G.M.M., Zimmet, P. and Shaw, J. (2006) Metabolic Syndrome—A New World-Wide Definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine, 23, 469-480.[CrossRef] [PubMed]
[3] Grundy, S.M. (2016) Metabolic Syndrome Update. Trends in Cardiovascular Medicine, 26, 364-373.[CrossRef] [PubMed]
[4] Saklayen, M.G. (2018) The Global Epidemic of the Metabolic Syndrome. Current Hypertension Reports, 20, Article No. 12.[CrossRef] [PubMed]
[5] Lin, X., Zhang, X., Guo, J., Roberts, C.K., McKenzie, S., Wu, W., et al. (2015) Effects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association, 4, e002014.[CrossRef] [PubMed]
[6] Campos, T.Y.T.B., et al. (2017) Pode a associação de laser de baixa intensidade e treinamento e treinamento intervalado de alta intesindade (HIIT) melhorar a composição corporal de mulheres em condições de pós menopausa? RBONERevista de Obesidade, nutrição e Emagrecimento, 11, 297-303.
[7] Da Silva, M.A.R., Baptista, L.C., Neves, R.S., De França, E., Loureiro, H., Lira, F.S., et al. (2020) The Effects of Concurrent Training Combining Both Resistance Exercise and High-Intensity Interval Training or Moderate-Intensity Continuous Training on Metabolic Syndrome. Frontiers in Physiology, 11, Article 572.[CrossRef] [PubMed]
[8] Myers, J., et al. (2015) Exercise and Cardiovascular Health. Circulation, 122, 163-172.
[9] Strasser, B., Arvandi, M. and Siebert, U. (2012) Resistance Training, Visceral Obesity and Inflammatory Response: A Review of the Evidence. Obesity Reviews, 13, 578-591.[CrossRef] [PubMed]
[10] Rognmo, Ø., Moholdt, T., Bakken, H., Hole, T., Mølstad, P., Myhr, N.E., et al. (2012) Cardiovascular Risk of High-versus Moderate-Intensity Aerobic Exercise in Coronary Heart Disease Patients. Circulation, 126, 1436-1440.[CrossRef] [PubMed]
[11] Church, T.S., Blair, S.N., Cocreham, S., Johannsen, N., Johnson, W., Kramer, K., et al. (2010) Effects of Aerobic and Resistance Training on Hemoglobin A1c Levels in Patients with Type 2 Diabetes: A Randomized Controlled Trial. JAMA, 304, 2253-2262.[CrossRef] [PubMed]
[12] Phillips, S.M. and Winett, R.A. (2010) Uncomplicated Resistance Training and Health-Related Outcomes: Evidence for a Public Health Mandate. Current Sports Medicine Reports, 9, 208-213.[CrossRef] [PubMed]
[13] Eckel, R.H., Grundy, S.M. and Zimmet, P.Z. (2005) The Metabolic Syndrome. The Lancet, 365, 1415-1428.[CrossRef] [PubMed]
[14] Green, D.J., Hopman, M.T.E., Padilla, J., Laughlin, M.H. and Thijssen, D.H.J. (2017) Vascular Adaptation to Exercise in Humans: Role of Hemodynamic Stimuli. Physiological Reviews, 97, 495-528.[CrossRef] [PubMed]
[15] Richter, E.A., Sylow, L. and Hargreaves, M. (2022) Interactions between Insulin and Exercise. Biochemical Journal, 479, 1033-1051.
[16] Huang, G., Wang, R., Chen, P., Huang, S.C., Donnelly, J.E. and Mehlferber, J.P. (2015) Dose-Response Relationship of Cardiorespiratory Fitness Adaptation to Controlled Endurance Training in Sedentary Older Adults. European Journal of Preventive Cardiology, 23, 518-529.[CrossRef] [PubMed]
[17] Swift, D.L., McGee, J.E., Earnest, C.P., Carlisle, E., Nygard, M. and Johannsen, N.M. (2018) The Effects of Exercise and Physical Activity on Weight Loss and Maintenance. Progress in Cardiovascular Diseases, 61, 206-213.[CrossRef] [PubMed]
[18] Barbat-Artigas, S., Rolland, Y., Vellas, B. and Aubertin-Leheudre, M. (2013) Muscle Quantity and Function in Middle-Aged and Older Adults: Influence of Obesity and Metabolic Syndrome. Obesity Reviews, 14, 740-749.
[19] Slentz, C.A., Bateman, L.A., Willis, L.H., Shields, A.T., Tanner, C.J., Piner, L.W., et al. (2011) Effects of Aerobic vs. Resistance Training on Visceral and Liver Fat Stores, Lipids, and Lipoproteins in Overweight Adults. Journal of Applied Physiology, 111, 687-693.
[20] Willis, L.H., Slentz, C.A., Bateman, L.A., Shields, A.T., Piner, L.W., Bales, C.W., et al. (2012) Effects of Aerobic and/or Resistance Training on Body Mass and Fat Mass in Overweight or Obese Adults. Journal of Applied Physiology, 113, 1831-1837.[CrossRef] [PubMed]
[21] Hardie, D.G., Ross, F.A. and Hawley, S.A. (2012) AMPK: A Nutrient and Energy Sensor That Maintains Energy Homeostasis. Nature Reviews Molecular Cell Biology, 13, 251-262.[CrossRef] [PubMed]
[22] Steinberg, G.R. and Carling, D. (2019) Amp-activated Protein Kinase: The Current Landscape for Drug Development. Nature Reviews Drug Discovery, 18, 527-551.[CrossRef] [PubMed]
[23] Li, Y., Xu, S., Mihaylova, M.M., Zheng, B., Hou, X., Jiang, B., et al. (2011) AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America, 108, 14516-14521.
[24] Fullerton, M.D., Steinberg, G.R. and Schertzer, J.D. (2013) Immunometabolism of AMPK in Insulin Resistance and Atherosclerosis. Molecular and Cellular Endocrinology, 366, 224-234.[CrossRef] [PubMed]
[25] Hood, D.A., Uguccioni, G., Vainshtein, A. and D’souza, D. (2011) Mechanisms of Exercise-Induced Mitochondrial Biogenesis in Skeletal Muscle: Implications for Health and Disease. Comprehensive Physiology, 1, 1119-1134.[CrossRef]
[26] Richter, E.A. and Hargreaves, M. (2013) Exercise, GLUT4, and Skeletal Muscle Glucose Uptake. Physiological Reviews, 93, 993-1017.[CrossRef] [PubMed]
[27] Petersen, A.M.W. and Pedersen, B.K. (2005) The Anti-Inflammatory Effect of Exercise. Journal of Applied Physiology, 98, 1154-1162.[CrossRef] [PubMed]
[28] Kawanishi, N., et al. (2010) Exercise Training Attenuates Adipose Tissue Inflammation in Diet-Induced Obese Mice. American Journal of Physiology-Endocrinology and Metabolism, 299, E116-E125.
[29] Pedersen, B.K. and Febbraio, M.A. (2012) Muscles, Exercise and Obesity: Skeletal Muscle as a Secretory Organ. Nature Reviews Endocrinology, 8, 457-465.[CrossRef] [PubMed]
[30] Koivisto, V.A., Eriksson, J. and Taimela, S. (1997) Exercise and the Metabolic Syndrome. Diabetologia, 40, 125-135.[CrossRef] [PubMed]
[31] Weltan, S.M., Bosch, A.N., Dennis, S.C. and Noakes, T.D. (1998) Influence of Muscle Glycogen Content on Metabolic Regulation. American Journal of Physiology-Endocrinology and Metabolism, 274, E72-E82.[CrossRef] [PubMed]
[32] Nitert, M.D., Dayeh, T., Volkov, P., Elgzyri, T., Hall, E., Nilsson, E., et al. (2012) Impact of Exercise Training on DNA Methylation in Skeletal Muscle. Diabetes, 61, 3861-3871.
[33] Garber, C.E., Blissmer, B., Deschenes, M.R., Franklin, B.A., Lamonte, M.J., Lee, I., et al. (2011) Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults. Medicine & Science in Sports & Exercise, 43, 1334-1359.[CrossRef] [PubMed]
[34] Swift, D.L., Johannsen, N.M., Lavie, C.J., Earnest, C.P. and Church, T.S. (2014) The Role of Exercise and Physical Activity in Weight Loss and Maintenance. Progress in Cardiovascular Diseases, 56, 441-447.[CrossRef] [PubMed]
[35] Peterson, M.D., Rhea, M.R., Sen, A. and Gordon, P.M. (2010) Resistance Exercise for Muscular Strength in Older Adults: A Meta-Analysis. Ageing Research Reviews, 9, 226-237.[CrossRef] [PubMed]
[36] Fiatarone, M.A., O’Neill, E.F., Ryan, N.D., Clements, K.M., Solares, G.R., Nelson, M.E., et al. (1994) Exercise Training and Nutritional Supplementation for Physical Frailty in Very Elderly People. New England Journal of Medicine, 330, 1769-1775.[CrossRef] [PubMed]
[37] Church, T.S., Earnest, C.P., Skinner, J.S. and Blair, S.N. (2007) Effects of Different Doses of Physical Activity on Cardiorespiratory Fitness among Sedentary, Overweight or Obese Postmenopausal Women with Elevated Blood Pressure. JAMA, 297, 2081-2091.[CrossRef] [PubMed]
[38] Green, B.N. and Johnson, C.D. (2006) How to Write a Narrative Review Article. Journal of Chiropractic Medicine, 5, 101-17.
[39] Ferrari, R. (2015) Writing Narrative Style Literature Reviews. Medical Writing, 24, 230-235.[CrossRef]
[40] Grant, M.J. and Booth, A. (2009) A Typology of Reviews: An Analysis of 14 Review Types and Associated Methodologies. Health Information & Libraries Journal, 26, 91-108.[CrossRef] [PubMed]
[41] Baethge, C., Goldbeck-Wood, S. and Mertens, S. (2019) SANRA—A Scale for the Quality Assessment of Narrative Review Articles. Research Integrity and Peer Review, 4, Article No. 5.[CrossRef] [PubMed]
[42] Gleeson, M., Bishop, N.C., Stensel, D.J., Lindley, M.R., Mastana, S.S. and Nimmo, M.A. (2011) The Anti-Inflammatory Effects of Exercise: Mechanisms and Implications for the Prevention and Treatment of Disease. Nature Reviews Immunology, 11, 607-615.[CrossRef] [PubMed]
[43] Choi, K.M., et al. (2007) Effects of Exercise on Circulating Adipokine Levels and Insulin Resistance in Obese Children. International Journal of Obesity, 31, 1022-1028.
[44] Pereira, J.M.O. and Cabral, P. (2007) Avaliação dos conhecimentos básicos sobre nutrição de praticantes de musculação em uma academia de Recife. Revista Brasileira de Nutrição Esportiva, 1, 40-47.
[45] Pedersen, B.K. and Saltin, B. (2015) Exercise as Medicine—Evidence for Prescribing Exercise as Therapy in 26 Different Chronic Diseases. Scandinavian Journal of Medicine & Science in Sports, 25, 1-72.[CrossRef] [PubMed]
[46] Collins, J.A. and Fauser, B.C.J.M. (2005) Balancing the Strengths of Systematic and Narrative Reviews. Human Reproduction Update, 11, 103-104.[CrossRef] [PubMed]

Copyright © 2026 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.